These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24086048)

  • 1. Methods for analysis of the immune system in mouse cancer models.
    Bayne LJ; Vonderheide RH
    Cold Spring Harb Protoc; 2013 Oct; 2013(10):901-3. PubMed ID: 24086048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicolor flow cytometric analysis of immune cell subsets in tumor-bearing mice.
    Bayne LJ; Vonderheide RH
    Cold Spring Harb Protoc; 2013 Oct; 2013(10):955-60. PubMed ID: 24086051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural immunity to cancer in humans.
    Bindea G; Mlecnik B; Fridman WH; Pagès F; Galon J
    Curr Opin Immunol; 2010 Apr; 22(2):215-22. PubMed ID: 20207124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptive immune response to sporadic cancer.
    Willimsky G; Blankenstein T
    Immunol Rev; 2007 Dec; 220():102-12. PubMed ID: 17979842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "In vitro" 3D models of tumor-immune system interaction.
    Hirt C; Papadimitropoulos A; Mele V; Muraro MG; Mengus C; Iezzi G; Terracciano L; Martin I; Spagnoli GC
    Adv Drug Deliv Rev; 2014 Dec; 79-80():145-54. PubMed ID: 24819215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cells as anti-cancer therapeutic targets and tools.
    Johansson M; Tan T; de Visser KE; Coussens LM
    J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells in cancer patients: a clinical perspective.
    Montero AJ; Diaz-Montero CM; Kyriakopoulos CE; Bronte V; Mandruzzato S
    J Immunother; 2012; 35(2):107-15. PubMed ID: 22306898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.
    Bronte V; Cingarlini S; Marigo I; De Santo C; Gallina G; Dolcetti L; Ugel S; Peranzoni E; Mandruzzato S; Zanovello P
    Immunol Invest; 2006; 35(3-4):327-57. PubMed ID: 16916757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cells as mediators of solid tumor metastasis.
    DeNardo DG; Johansson M; Coussens LM
    Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-mediated dormancy: an equilibrium with cancer.
    Teng MW; Swann JB; Koebel CM; Schreiber RD; Smyth MJ
    J Leukoc Biol; 2008 Oct; 84(4):988-93. PubMed ID: 18515327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor.
    Kuznetsov VA; Zhivoglyadov VP; Stepanova LA
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):21-31. PubMed ID: 8239905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of immune systems from self/not self to danger to artificial immune systems (AIS).
    Cooper EL
    Phys Life Rev; 2010 Mar; 7(1):55-78. PubMed ID: 20374928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic.
    Hong EH; Chang SY; Lee BR; Pyun AR; Kim JW; Kweon MN; Ko HJ
    Vaccine; 2013 Feb; 31(10):1377-84. PubMed ID: 23318147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?
    Hamaï A; Benlalam H; Meslin F; Hasmim M; Carré T; Akalay I; Janji B; Berchem G; Noman MZ; Chouaib S
    Tissue Antigens; 2010 Jan; 75(1):1-8. PubMed ID: 20196816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDT-associated host response and its role in the therapy outcome.
    Korbelik M
    Lasers Surg Med; 2006 Jun; 38(5):500-8. PubMed ID: 16634073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How is the immune response affected by hyperthermia and heat shock proteins?
    Calderwood SK; Theriault JR; Gong J
    Int J Hyperthermia; 2005 Dec; 21(8):713-6. PubMed ID: 16338853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells--why can they help and hurt us.
    Schäkel K
    Exp Dermatol; 2009 Mar; 18(3):264-73. PubMed ID: 19183400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective.
    Desjarlais JR; Lazar GA; Zhukovsky EA; Chu SY
    Drug Discov Today; 2007 Nov; 12(21-22):898-910. PubMed ID: 17993407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.